Domino's Pizza Inc

The company provides a high-level disclosure of its key purchased proteins. In its 2023 annual report, it highlights that cheese represents 25% of the market basket purchased by its company-owned stores. It also discloses that its basic menu includes ‘boneless chicken and chicken wings’. On its US website, the animal proteins offered for building a pizza include ‘Bacon, Beef, Ham, Italian Sausage, Pepperoni, Philly Steak, Premium Chicken, and Salami’. On its French website, the company offers two fish pizzas, the ‘Nordique’ (containing smoked salmon) and the ‘Océana’ (containing tuna). It is unclear if the fish is wild-caught or farmed.

According to the company website, all of the chicken used for pizzas, sandwiches, wings, boneless chicken, and pasta are raised without antibiotics that are medically important to humans. It has included this in each of its CS reports from 2019-2022. In its 2023 CS report, the company states that all of its chicken products are from animals raised without ‘antibiotics important to human medicine’. It is unclear if this definition is the same as medically important antimicrobials as defined by the WHO. In its 2023 CS report, the company expresses an intent to transition to pork and beef raised without the routine use of MIA but has not disclosed any policies or targets for achieving this. The company does not disclose any antibiotic policies for the seafood or dairy it purchases.

In its 2023 CS report, the company states that all of its chicken products are from animals raised without ‘antibiotics important to human medicine’. The report covers the US and Canadian base supply chain, including US corporate-owned stores (288), corporate office operations, and US franchised stores (6566). The company stated that its supply chain centres cover all of its US stores and the majority of its franchised stores in Canada, of which there are 605. This leaves an estimates 13,132 franchised stores globally (64% of its total stores) that are not currently covered by its broiler policy.

The company disclosed that its chicken products in its US and Canadian base supply chain, corporate-owned stores, corporate office operations, and US franchised stores, were raised without the routine use of antibiotics important to human health. The company does not publicly report that it collects information on the volume of antibiotics used in its supply chain for any of its other key proteins or locations.

The company does not disclose evidence that antibiotic use in its poultry is audited by a third party.

In its 2023 CS report, the company states that all of its chicken products in its US and Canadian base supply chain, corporate-owned stores, corporate office operations, and US franchised stores are ‘from animals raised without antibiotics important to human medicine’. Outside of this statement, the company does not provide any evidence that it is tracking levels of non-compliance. It also does not disclose how it manages non-compliance related to this policy.

Outside of the company’s achievements in its poultry supply for its US corporate stores, supply chain centres in the US and Canada, and US franchised stores, the company does not disclose evidence of an antibiotic reduction target for any of its key animal proteins.

This is not applicable as Domino’s has not set any targets to reduce antibiotic use in its supply chain.

This is not applicable as Domino’s has not set any targets to reduce antibiotic use in its supply chain.

The company declined to provide a written response or participate in a company dialogue.